Black Titan (NASDAQ:BTTC) Posts Earnings Results

Black Titan (NASDAQ:BTTC) announced its quarterly earnings data on Tuesday. The company reported ($1.81) EPS for the quarter, FiscalAI reports.

Black Titan Trading Down 1.2%

Shares of BTTC stock traded down $0.02 during trading hours on Thursday, hitting $1.59. The stock had a trading volume of 55,741 shares, compared to its average volume of 2,394,407. The company has a market capitalization of $14.45 million, a P/E ratio of -0.54 and a beta of 1.38. Black Titan has a twelve month low of $1.51 and a twelve month high of $39.00.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings initiated coverage on shares of Black Titan in a report on Monday, January 26th. They set a “sell (e-)” rating on the stock. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Black Titan presently has an average rating of “Sell”.

Institutional Investors Weigh In On Black Titan

A number of institutional investors and hedge funds have recently made changes to their positions in BTTC. Renaissance Technologies LLC purchased a new position in shares of Black Titan during the fourth quarter worth about $26,000. HRT Financial LP acquired a new stake in Black Titan during the 4th quarter worth approximately $28,000. Marex Group plc purchased a new position in shares of Black Titan in the 4th quarter valued at approximately $84,000. Finally, Armistice Capital LLC acquired a new position in shares of Black Titan in the fourth quarter valued at approximately $840,000.

Black Titan Company Profile

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.